Celgene Corp (CELG) Tops Q3 EPS by 2c; Bumps Guidance Higher
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q3 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.41 billion.
Celgene Corp sees FY2012 EPS of $4.85-4.90, versus prior guidance of $4.80-4.85 and the consensus of $4.88. Celgene Corp sees FY2012 revenue of $5.45-5.55 billion, versus prior guidance of $5.4-5.6 billion and the consensus of $5.5 billion.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Celgene Corp sees FY2012 EPS of $4.85-4.90, versus prior guidance of $4.80-4.85 and the consensus of $4.88. Celgene Corp sees FY2012 revenue of $5.45-5.55 billion, versus prior guidance of $5.4-5.6 billion and the consensus of $5.5 billion.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
